SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-014277
Filing Date
2019-04-30
Accepted
2019-04-30 16:10:53
Documents
6
Period of Report
2019-06-18
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A arpo-def14a_20190618.htm DEF 14A 750342
2 GRAPHIC gag4mmlbq24q000003.jpg GRAPHIC 91040
3 GRAPHIC gag4mmlbq24q000005.jpg GRAPHIC 43489
4 GRAPHIC gag4mmlbq24q000002.jpg GRAPHIC 4440
5 GRAPHIC gag4mmlbq24q000004.jpg GRAPHIC 68533
6 GRAPHIC gag4mmlbq24q000001.jpg GRAPHIC 4050
  Complete submission text file 0001564590-19-014277.txt   1043498
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 19781792
SIC: 2834 Pharmaceutical Preparations